Sung-Hwan Cho
Amministratore Delegato presso CHOA PHARMACEUTICAL CO., LTD.
Patrimonio netto: 2 M $ in data 31/05/2024
Posizioni attive di Sung-Hwan Cho
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CHOA PHARMACEUTICAL CO., LTD. | Direttore/Membro del Consiglio | 18/02/2002 | - |
| Amministratore Delegato | - | - | |
| Presidente | - | - | |
Medipharm
 Medipharm Medical DistributorsDistribution Services Medipharm, founded in 2015, is a cannabis concentrate and derivative product manufacturer based in Seongnam, South Korea. The South Korean company has a good manufacturing practices certified facility with ISO standard-built clean rooms and five primary extraction lines for delivering pure and precision-dosed cannabis products. Medipharm invests in research-driven teams, state-of-the-art technology, and downstream purification methodologies to formulate, develop, process, package, and distribute cannabis extracts and advanced cannabinoid-based products to domestic and international markets. The CEO of the private company is Sung-Hwan Cho. | Amministratore Delegato | - | - |
| Presidente | - | - |
Storia della carriera di Sung-Hwan Cho
Formazione di Sung-Hwan Cho
| Korea University | Undergraduate Degree |
| Chung-Ang University | Graduate Degree |
Statistiche
Distribuzione geografica
| Corea del Sud | 5 |
Posizioni
| President | 2 |
| Chief Executive Officer | 2 |
| Director/Board Member | 1 |
Settori
| Consumer Services | 3 |
| Health Technology | 2 |
| Distribution Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CHOA PHARMACEUTICAL CO., LTD. | Health Technology |
| Aziende private | 1 |
|---|---|
Medipharm
Medipharm Medical DistributorsDistribution Services Medipharm, founded in 2015, is a cannabis concentrate and derivative product manufacturer based in Seongnam, South Korea. The South Korean company has a good manufacturing practices certified facility with ISO standard-built clean rooms and five primary extraction lines for delivering pure and precision-dosed cannabis products. Medipharm invests in research-driven teams, state-of-the-art technology, and downstream purification methodologies to formulate, develop, process, package, and distribute cannabis extracts and advanced cannabinoid-based products to domestic and international markets. The CEO of the private company is Sung-Hwan Cho. | Distribution Services |
- Borsa valori
- Insiders
- Sung-Hwan Cho
- Esperienza
